Viewing Study NCT00094835

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:38 PM
Ignite Modification Date: 2026-02-26 @ 12:41 AM
Study NCT ID: NCT00094835
Status: COMPLETED
Last Update Posted: 2016-03-24
First Post: 2004-10-27
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Study to Evaluate Motesanib With or Without Carboplatin/Paclitaxel or Panitumumab in the Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
None Non-Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lung cancer, Non-small cell lung cancer, NSCLC View
None Clinical Trial, Panitumumab, AMG 706 View
None Anti-angiogenesis View
None Immunex, Abgenix, Amgen View
None Stage IIIB, Stage IV, Unresectable View